U.S. Physical Therapy, Inc. - 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for U.S. Physical Therapy, Inc. for the period ended June 30, 2001. The Company operates 149 outpatient physical and occupational therapy clinics across 30 states, providing post-operative care and treatment for orthopedic and sports-related injuries. As of the reporting date, the Company also managed six third-party facilities.
Key Financial Metrics (Six Months Ended June 30, 2001)
| Metric | 2001 (YTD) | 2000 (YTD) | Change |
|---|---|---|---|
| Net Revenues | $38,796,000 | $30,647,000 | +26.6% |
| Net Income | $3,299,000 | $1,609,000 | +105.0% |
| Diluted EPS | $0.26 | $0.15 | +73.3% |
| Operating Cash Flow | $6,357,000 | $4,272,000 | +48.8% |
| Cash & Equivalents | $6,612,000 | $5,323,000 | +24.2% |
| Convertible Debt | $3,000,000 | $7,200,000 | -58.3% |
| Debt-to-Equity Ratio | 0.15 | 0.85 | Significant Improvement |
Note: All figures in thousands except per share data and ratios.
Material Changes vs. Prior Period
- Revenue Growth: Net patient revenues increased 28% year-over-year, driven by a 24% increase in patient visits (419,000 vs. 339,000) and the opening of 22 new clinics. Mature clinics contributed the majority of the revenue increase.
- Profitability: Net income more than doubled due to revenue growth and a significant reduction in interest expense.
- Debt Reduction: The Company converted $5.05 million of convertible subordinated debt into common stock, reducing interest expense by 60% ($218,000 decrease YTD) and improving the debt-to-equity ratio from 0.85 to 0.15.
- Cost Management: Clinic operating costs as a percentage of revenue decreased to 68% from 72%. Recruitment and development costs dropped 31% due to the discontinuation of a surgery center initiative in the prior year.
- Stock Splits: The Company executed a two-for-one stock split in January 2001 and a three-for-two split in June 2001. All share data has been adjusted.
Guidance, Outlook, and Risks
- Expansion Goals: Management aims to open between 30 and 35 clinics in 2001. New clinics are expected to incur initial operating losses before becoming profitable over 2-3 years.
- Liquidity: The Company holds $6.6 million in cash and cash equivalents. Management believes existing funds and operating cash flows are sufficient to meet needs through 2002.
- Accounting Changes: The Company adopted SFAS 133 (Derivatives) with no material effect. Future adoption of SFAS 142 (Goodwill) in 2002 is expected to eliminate approximately $70,000 in annual amortization expense, though impairment testing will be required.
- Risks: Forward-looking statements are subject to risks including regulatory changes, competition, and the ability to identify suitable locations and partners for new clinics.
Investor Verification Checklist
- Debt Conversion Impact: Verify the dilution effect of converting $5.05 million of debt into approximately 1.2 million shares of common stock.
- New Clinic Performance: Monitor the ramp-up period for the 22 new clinics opened since mid-2000 to ensure they meet projected profitability timelines.
- Minority Interests: Review the increasing minority interest in subsidiary partnerships ($2.6 million YTD), which reduces net income attributable to common shareholders.
- Payor Mix: Assess the impact of contractual adjustments and discounts from third-party payors (e.g., Medicare, workers' compensation) on net revenue per visit.
- Stock Split Adjustments: Confirm that all historical per-share data has been correctly restated for the January and June 2001 stock splits.